SLC2A1 and cancer: Wang et al. (2020) demonstrated that shRNA inhibits the survival of laryngeal carcinoma HEP2 cells via beclin-1-associated autophagy. shRNA to GLUT1 is also reported to effectively block glucose uptake in various cancer cell lines (Pliszka and Szablewski, 2021).